secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scienture Holdings, Inc. (SCNX)
CIK:        0001382574
Form:       8-K
Filed at:   2023-02-01T23:59:59+00:00
Accession:  0001493152-23-003204
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

TRxADE HEALTH receives Nasdaq delisting notice for failure to meet stockholders' equity requirement
--------------------------------------------------------------------------------

- Nasdaq notified TRxADE on Jan 30, 2023 that it did not meet terms of extension to comply with minimum $2.5M stockholders' equity rule.
- Trading of MEDS common stock will be suspended at opening on Feb 8, 2023 if no appeal requested.
- Company intends to request a hearing before Nasdaq Hearings Panel, which would stay delisting pending outcome.
- Company previously disclosed deficiency on July 29, 2022 and was granted extension until Jan 25, 2023.
- Delisting could impair ability to raise capital and cause material decline in stock price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382574/000149315223003204/0001493152-23-003204-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382574/000149315223003204/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-003204

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer